Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis

T. Houben, E. Brandsma, S. M. A. Walenbergh, M. H. Hofker, R. Shiri-Sverdlov*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

14 Citations (Web of Science)

Abstract

Non-alcoholic steatohepatitis (NASH) is viewed as the hepatic manifestation of the metabolic syndrome and is a condition hallmarked by lipid accumulation in the liver (steatosis) along with inflammation (hepatitis). Currently, the etiology and mechanisms leading to obesity-induced hepatic inflammation are not clear and, as a consequence, strategies to diagnose or treat NASH in an accurate manner do not exist. In the current review, we put forward the concept of oxidized lipids as a significant risk factor for NASH. We will focus on the contribution of the different types of oxidized lipids as part of the oxidized low-density lipoprotein (oxLDL) to the hepatic inflammatory response. Furthermore, we will elaborate on the underlying mechanisms linking oxLDL to inflammatory responses in the liver and on how these cascades can be used as therapeutic targets to combat NASH. This article is part of a Special Issue entitled: Lipid modification and lipid peroxidation products in innate immunity and inflammation edited by Christoph J. Binder. (C) 2016 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)416-429
Number of pages14
JournalBiochimica et Biophysica Acta-Molecular and Cell Biology of Lipids
Volume1862
Issue number4
DOIs
Publication statusPublished - Apr 2017

Keywords

  • OxLDL
  • Lipid metabolism
  • Hepatic inflammation
  • NASH
  • FATTY LIVER-DISEASE
  • LOW-DENSITY-LIPOPROTEIN
  • HEPATIC STELLATE CELLS
  • FECAL MICROBIOTA TRANSPLANTATION
  • SINUSOIDAL ENDOTHELIAL-CELLS
  • ACID-INDUCED LIPOTOXICITY
  • BLOOD CHOLESTEROL LEVELS
  • MACROPHAGE FOAM CELLS
  • OXIDATIVE STRESS
  • GUT MICROBIOTA

Cite this